Why the study?
Neural control of coronary blood flow has predominantly focused on classical neurotransmitters, but understanding the role of autonomic non-adrenergic, non-cholinergic cotransmitters is needed to develop novel targeted therapies.
Key points are not available for this paper at this time.
Design
Review
Highlights the importance of autonomic non-adrenergic, non-cholinergic cotransmitters in regulating coronary blood flow and their potential as therapeutic targets.
Blood flow through the coronary vasculature is essential to maintain myocardial function. As the metabolic demand of the heart increases, so does blood flow through the coronary arteries in a dynamic and adaptive manner. Several mechanisms, including local metabolic factors, mechanical forces and autonomic neural control, regulate coronary artery blood flow. To date, neural control has predominantly focused on the classical neurotransmitters of noradrenaline and acetylcholine. However, autonomic nerves, sympathetic, parasympathetic and sensory, release a variety of neurotransmitters that can directly affect the coronary vasculature. Reduced or altered coronary blood flow and autonomic imbalance are hallmarks of most cardiovascular diseases. Understanding the role of autonomic non-adrenergic, non-cholinergic cotransmitters in coronary blood flow regulation is fundamental to furthering our understanding of this vital system and developing novel targeted therapies.
No takes yet. Share an insight, caveat, or question.
Shanks et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: